Shanghai Kaibao Pharmaceutical CO.,Ltd announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 339.907 million compared to CNY 293.546 million a year ago. Operating income was CNY 68.247 million compared to CNY 62.381 million a year ago. Net income was CNY 57.237 million compared to CNY 52.708 million a year ago. Basic earnings per share from continuing operations was CNY 0.0547 compared to CNY 0.0504 a year ago.